Combined Electric and Acoustic Hearing (EAS) in Children and Adults

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

June 1, 2028

Study Completion Date

August 31, 2028

Conditions
Cochlear ImplantHearing Loss
Interventions
OTHER

Electric and acoustic stimulation (EAS) technology in the implanted ear(s)-this is the combination of a cochlear implant (CI) and hearing aid (HA) in the implanted ear(s)

This is a clinical fitting of an FDA approved EAS system for study participants that have received or who are scheduled to receive a CI based on clinical recommendations (i.e. not study related). The investigators will activate the CI sound processor's integrated HA circuit to allow for low-frequency acoustic amplification and mid-to-high frequency electric stimulation in the implanted ear(s) using recommended and accepted clinical practices and audiologic verification. EAS fitting will be completed using FDA approved clinical software and thereby is within the electrical and clinical specifications of the FDA approved device and accompanying software.

Trial Locations (4)

37232

COMPLETED

Vanderbilt University Medical Center, Nashville

53706

RECRUITING

University Of Wisconsin Madison, Madison

73120

RECRUITING

Hearts for Hearing, Edmond

78712

RECRUITING

University Of Texas at Austin, Austin

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Hearts for Hearing

OTHER